Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPINART secondary prophylaxis vs episodic rFVIII in severe hemophilia A
2008-000985-21Phase 4Completed
- Sponsor
- Bayer HealthCare
- Start
- Nov 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of Factor VIII in hemophilia A (2 arms), sponsored by Bayer HealthCare. Primary endpoint: Total number of all bleeds per year. Started Nov 2009; status: completed.
02
Drugs
Factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on 2008-000985-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000985-21.